A rare pediatric soft tissue tumor was analyzed to determine therapeutic targets. By combining multiple types of analysis, it was uncovered that this patient was eligible for a novel clinical trial containing MEK and PD-L1 checkpoint inhibitors.
Read MoreAcute Myeloid Leukemia (AML) constitutes 15-20% of all pediatric acute leukemias, with an average survival rate of 70%. However, the black/African American subgroup do significantly worse than whites with AML.
Read MoreProtean BioDiagnostics develops AI approach to detect specific EGFR mutations in lung cancer specimens using analysis of digital pathology images and will present findings at the AACR meeting.
Read MoreProtean BioDiagnostics develops AI approach to detect specific EGFR mutations in lung cancer specimens using analysis of digital pathology images and will present findings at the AACR meeting.
Read MoreProtean BioDiagnostics identifies key molecular differences in Colorectal cancer between men and women with implications for treatment and screening.
Read MoreProtean to present updates on the innovative use of digital pathology and image analysis for improved classification of the risk of malignant transformation of Barrett’s esophagus at USCAP.
Read More
